جستجوی استاد راهنمای دانشگاهی

Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .

• Computational Biology
• Machine Learning
• Molecular Dynamics Simulation
• +۶ مورد دیگر

Hang Lu is an Associate Professor in the Department of Communication and Media at the University of Michigan's College of Literature, Science, and the Arts. He specializes in science, health, environmental, and risk communication (ComSHER), with a focus on media psychology. His research explores audience responses to media messages about sensitive topics and strategies to enhance message effectiveness. Lu holds a Ph.D. in Communication from Cornell University (2018), along with advanced degrees from Cornell, Marquette University, and Central South University in China. He directs the Media and Risk (MaR) Lab and previously served as a postdoctoral fellow at the Annenberg Public Policy Center. His research spans four main areas: 1) emotion dynamics in media responses, 2) predictors of information behaviors, 3) media effects on stigmatization, and 4) AI applications in sensitive domains. He has published in journals like Journal of Communication , Risk Analysis , and Public Understanding of Science , earning multiple top paper awards. As Vice Chair of the Environmental Communication Division at the International Communication Association, Lu contributes to interdisciplinary dialogue. His work addresses critical societal issues such as climate change communication, vaccination hesitancy, and emerging technology ethics.

• Science Communication
• Health Communication
• Environmental Communication
• +۴ مورد دیگر

Hong Han is an Assistant Professor in the Department of Biochemistry & Biomedical Sciences within McMaster University's Faculty of Health Sciences and a member of the Centre for Discovery in Cancer Research (CDCR). She holds a Canada Research Chair and leads the Han Lab, which focuses on cancer biology, RNA regulation, and innovative high-throughput technologies for therapeutic discovery. Dr. Han earned her Ph.D. from the University of Toronto (2010-2016) and has established herself as a leading researcher in glioblastoma and alternative splicing regulation. Her interdisciplinary research integrates cancer biology, RNA science, and multilayer gene regulation to uncover mechanisms underlying cancer progression and treatment resistance. Her laboratory pioneers integrated technological platforms for large-scale genetic/drug screening and ultra-high-throughput single-cell profiling. The research focuses on three main areas: alternative splicing regulation in cancer (particularly glioblastoma and prostate cancer), multilayer mechanisms of glioblastoma heterogeneity and microenvironment evolution, and multiplexed screening approaches for therapeutic discovery in treatment-resistant cancers. Analysis of Dr. Han's recent publications reveals a strong emphasis on single-cell technologies to characterize glioblastoma heterogeneity, minimal residual disease states, and tumor-immune interactions. Her work increasingly bridges basic RNA biology with translational applications, particularly in developing novel therapeutic strategies targeting splicing networks and immune evasion mechanisms. Canada Research Chair Dr. Han teaches Advanced Techniques in the Biomedical Sciences (BIOCHEM 734). Her research program is supported by multiple funding sources, as evidenced by her extensive publication record in high-impact journals including Nature, Cell, Molecular Cell, and Nature Communications. She employs a comprehensive approach combining in vitro, in vivo, and patient cohort studies with cutting-edge genomic technologies. The Han Lab has developed innovative multiplexed screening platforms that enable simultaneous interrogation of thousands of conditions, ranging from CAR-T cells to small molecule therapeutics. This approach accelerates the discovery of novel cancer targets and therapeutic strategies for treatment-resistant cancers.

• Cancer Biology
• Gene Regulation
• RNA Splicing
• +۵ مورد دیگر

Markus Babst is a Professor of Biological Sciences at the University of Utah, where he leads research at the Center of Cell and Genome Science. His work focuses on protein trafficking mechanisms in eukaryotic cells using Saccharomyces cerevisiae as a primary model system. His educational background includes: Diploma from Federal Institute of Technology, Switzerland Ph.D. from Federal Institute of Technology, Switzerland Dr. Babst's research centers on post-translational regulation of plasma membrane proteins through endocytosis and endosomal sorting. Key investigations include ESCRT-mediated protein sorting into multivesicular bodies for lysosomal degradation and eisosome-regulated storage of nutrient transporters. His work demonstrates how calcium signaling and proton gradients control eisosome disassembly and transporter endocytosis, revealing fundamental mechanisms of cellular stress adaptation. This research bridges membrane biophysics, metabolic regulation, and organelle dynamics. Analysis of his 15 most recent publications shows persistent thematic focus on membrane tension regulation, ESCRT complex dynamics, and nutrient transporter control. His work increasingly integrates mitochondrial metabolism with plasma membrane organization while maintaining yeast genetics as the core methodology. Recurring subfields include membrane contact sites, lipid domain organization, and stress-induced protein trafficking changes. Dr. Babst's scientific contributions are evidenced by his extensive publication record in high-impact journals, though specific awards are not documented in available sources. While student mentorship details are unavailable in the provided materials, his laboratory employs biochemical, genetic, and cell biological approaches to investigate membrane protein regulation. Grant funding specifics are not mentioned in the source text. His laboratory operates within the University of Utah's biological research ecosystem, utilizing S. cerevisiae to dissect conserved eukaryotic mechanisms. Current work emphasizes plasma membrane tension dynamics, ER-plasma membrane contact sites, and metabolic regulation of membrane protein trafficking, with implications for understanding cellular adaptation in changing environments.

• Protein Trafficking
• ESCRT Complexes
• Eisosomes
• +۵ مورد دیگر

Canan ATILGAN is a Professor at the Faculty of Engineering and Natural Sciences, Sabanci University, Istanbul, Turkey. She has held leadership roles including Dean (2018-2020), Director of the Graduate School (2018-2020), and President of the Science Academy (2021-present). Her research focuses on computational tools for protein conformational transitions, allosteric communication, and antibiotic resistance mechanisms. Ph.D. (1996) and B.S. (1991) in Chemical Engineering from Boğaziçi University A pioneer in perturbation-response scanning and network-based protein modeling, her work bridges biophysics, structural biology, and molecular evolution. She has supervised 15 PhD and 17 MS students, emphasizing accessible computational biophysics education through workshops and seminars. Her recent publications highlight allosteric mechanisms in biosensors, β-lactam resistance via TolC dynamics, and evolutionary fitness landscapes. Awards include EMBO and Academia Europaea membership, L’Oréal Turkey Young Women Scientist Fellowship, and TÜBA-GEBİP Distinguished Young Scientist Award. President, Science Academy (2021) EMBO Elected Member (2023) TÜBA-GEBİP Distinguished Young Scientist (2004) She leads the MIDST Lab, contributes to Turkish science communication via sarkac.org, and organizes 'Dialogues in the MIDST' workshops for graduate students. Her work integrates theoretical models with experimental validation in iron transport proteins and resistance mechanisms.

• Biophysics
• Structural Biology
• Computational Biology
• +۳ مورد دیگر

David N. Langelaan is an Associate Professor in the Department of Biochemistry and Molecular Biology at Dalhousie University, within the Faculty of Medicine. He holds a PhD from Dalhousie University and has been a department member since 2016. His research focuses on structural biology, protein-protein interactions, cellular signaling, and protein engineering. Key projects include hydrophobin characterization and engineering, studying MITF's role in melanoma and development, and analyzing rhodoquinone biosynthesis in anaerobic environments. Education: PhD, Dalhousie University. Research Themes: Structural biology, protein assemblies, microbial biochemistry, cancer biology. His lab employs techniques like NMR spectroscopy, X-ray crystallography, and isothermal titration calorimetry. Current lab members include graduate students (Raymond He, Trilok Neupane) and honours students (Alex Bouchard, Janani Venkat). Funding is provided by agencies such as NSERC, CFI, and the Dalhousie Medical Research Foundation. Publications highlight contributions to antimicrobial mechanisms, transcription factor signaling, and hydrophobin self-assembly. Recent work examines MITF coactivator interactions and rhodoquinone biosynthesis pathways in bacteria.

• Structural Biology
• Protein-Protein Interactions
• Cellular Signaling
• +۵ مورد دیگر

Ramanujan Hegde serves as a Professor and Group Leader at the MRC Laboratory of Molecular Biology (LMB), University of Cambridge, where he directs research on membrane protein biosynthesis and cellular quality control mechanisms. His work examines how membrane proteins are accurately targeted to organelles, inserted into lipid bilayers, folded, and assembled into functional complexes, with emphasis on the cellular pathways that eliminate defective proteins to prevent disease. Professor Hegde's research program focuses on fundamental questions in cell biology: How do cells ensure precise membrane protein localization? What molecular machinery governs protein insertion and folding? How do quality control systems detect and degrade misfolded proteins? His investigations reveal that biosynthetic failures are common, triggering degradation pathways linked to diseases like neurodegeneration. Key research areas include: Intramembrane chaperone mechanisms for multipass membrane proteins Orphan subunit recognition during complex assembly Ribosome-associated mRNA degradation in autoregulation Proteasome assembly quality control ER membrane protein complex functions Molecular basis of protein aggregation diseases His 2017-2023 publications in Cell, Nature, and Science demonstrate consistent innovation in protein quality control, with landmark discoveries including UBE2O's role in orphan subunit degradation, the EMC as a transmembrane domain insertase, and TTC5-mediated tubulin autoregulation. These works bridge basic cell biology with disease mechanisms through rigorous biochemical and structural approaches. Professor Hegde mentors a research team of 11 scientists: Christine Desroches Altamirano Zhong Yan Gan Dino Janssen Ryan Judy Jennifer Miao Elizabeth Miller Tim Stevens Julia Toplak Huping Wang Haoxi Wu Eszter Zavodszky His laboratory operates within the MRC LMB's world-class infrastructure, utilizing advanced techniques in biochemistry, structural biology, and cell imaging. Supported by Medical Research Council funding, the group maintains strong collaborations across Cambridge and internationally to dissect protein biogenesis pathways with implications for therapeutic development in protein-misfolding disorders.

• Cell Biology
• Molecular Biology
• Membrane Proteins
• +۳ مورد دیگر

Nathaniel Nucci is an Associate Professor at Rowan University's College of Science & Mathematics, jointly appointed in the Department of Biological & Biomedical Sciences and Physics & Astronomy. His research bridges biophysics, structural biology, and nanotechnology to understand protein behavior in confined environments. Education Ph.D., Biochemistry and Molecular Biophysics, University of Pennsylvania M.S., Biochemistry and Molecular Biology, University of New Hampshire B.S., Biochemistry and Molecular Biology, University of New Hampshire Research Interests Dr. Nucci's lab focuses on: Protein biophysics in crowded/confining environments Reverse micelle technology for biomolecular studies Hydration dynamics of proteins (NMR-based methods) Structural biology of disease-related proteins (PHDs, p53) Drug delivery systems for protein therapeutics Nanoparticle synthesis with protein conjugation Research Trends His recent publications demonstrate expertise in using reverse micelles to study: Protein structural stability under confinement Hydration dynamics of therapeutic proteins Microenvironmental effects on phase-separating proteins Conformational changes in GPCRs Interfacial interactions in biomolecular systems Scientific Awards Gary J. Hunter Excellence in Mentoring Award (2024) College of Science and Mathematics Excellence in Academic Student Support (2022) Teaching Philosophy Emphasizes applied and experiential learning, integrating recent scientific discoveries into classroom practice and promoting hands-on scientific investigation.

• Protein Biophysics
• Spectroscopy
• Drug Development
• +۱۱ مورد دیگر

John E. Straub is a Professor in the Department of Chemistry at Boston University (BU), where he leads the Straub Lab. His work focuses on molecular dynamics and thermodynamics of complex biomolecular systems, particularly protein aggregation and amyloid formation. He has authored influential books, including Proteins: Energy, Heat and Signal Flow and Mathematical Methods for Molecular Science , and has held leadership roles such as Chair of the Department of Chemistry at BU (2007-2012) and President of the Telluride Science Research Center (2006-2008). Education: BS in Chemistry (University of Maryland, 1982, advisor: Millard Alexander) MA (Columbia University, 1984) MPhil (Columbia University, 1986) PhD in Chemical Physics (Columbia University, 1987, advisor: Bruce Berne) NIH Postdoctoral Fellow in Chemistry (Harvard University, 1987-1990, advisor: Martin Karplus) His research interests span computational methods for enhanced sampling, reaction dynamics, and the interplay between protein structure and aggregation. He has pioneered studies on amyloid precursor proteins and cholesterol interactions in lipid bilayers, emphasizing the role of monomer structural ensembles in aggregation mechanisms. Articles from his lab highlight advancements in understanding lipid phase separation, amyloid fibril formation, and computational techniques like machine learning-derived variables and replica exchange methods. His work bridges theory and experiment, with collaborations across institutions globally. Scientific Awards: NIH Postdoctoral Fellowship (Harvard University, 1987-1990). Professor Straub has advised numerous students, many of whom hold academic positions at leading institutions, including Jianpeng Ma (Rice University) and Nicolae-Viorel Buchete (University College Dublin). His lab actively explores projects in computational biophysics, with ongoing work on lipid mixtures, sterol-derived Raman tags, and membrane protein interactions.

• Molecular Dynamics
• Thermodynamics
• Protein Aggregation
• +۷ مورد دیگر

Dr. Ross Dalbey is a Full Professor in the Department of Chemistry and Biochemistry at The Ohio State University, affiliated with the College of Arts and Sciences. He holds a B.S. in Chemistry from the University of Washington (1978) and a Ph.D. in Biochemistry from Washington State University (1983). Postdoctoral training included work with Prof. William Wickner at UCLA. His research focuses on membrane protein assembly and proteases, particularly the YidC protein's role in membrane insertion and folding. Key areas include biophysical mechanisms of protein insertion, signal peptidase function, and mitochondrial membrane systems. He has held NIH and AAAS fellowships, and his lab has been funded by NIH and NSF for over three decades. His students hold academic and industry positions at institutions like NIH, MIT, and pharmaceutical companies such as Eli Lilly. Education: B.S., Chemistry, University of Washington, 1978 Ph.D., Biochemistry, Washington State University, 1983 Awards: American Cancer Society Junior Faculty Award (1989–1992) Elected Fellow of the American Association for the Advancement of Science (AAAS) Professional Memberships: American Chemical Society Federation of American Societies for Experimental Biology American Society of Microbiology Sigma Xi Phi Kappa Phi His lab investigates how proteins are inserted into membranes and folded, with emphasis on the YidC/Oxa1 family of insertases. Recent work explores YidC's substrate specificity, dimeric structure, and interactions with the Sec translocon. Studies on proteases like signal peptidase reveal their roles in membrane-associated peptide cleavage. Collaborations include structural biology with Prof. Horst Vogel in Switzerland and functional analyses with Prof. White at Ohio State. Research highlights include defining YidC's role in multispan membrane protein integration and uncovering evolutionary conservation across bacterial, archaeal, and eukaryotic systems. The lab's findings contribute to understanding mitochondrial protein insertion pathways and drug design targeting membrane-associated enzymes.

• Biochemistry
• Membrane Biology
• Proteins
• +۳ مورد دیگر

Jonathan Weissman is a Professor of Biology at the Massachusetts Institute of Technology (MIT) and a Member of the Whitehead Institute. He is also an Investigator of the Howard Hughes Medical Institute and the Landon T. Clay Professor of Biology. His research spans protein folding mechanisms, ribosome profiling, CRISPR-based tools (CRISPRi/a), and genetic interaction mapping. Whitehead Institute Member MIT Professor HHMI Investigator Co-founder, Maze Therapeutics & KSQ Therapeutics Research Interests focus on: Protein folding in cellular contexts Endoplasmic reticulum (ER) function and stress responses Genome-wide CRISPR screening for gene regulation High-density genetic interaction maps in mammals Mitochondrial protein targeting and quality control Epigenomic engineering with synthetic tools Scientific Awards include: Protein Society Irving Sigal Young Investigator Award (2004) Raymond & Beverly Sackler Prize (2008) National Academy of Sciences election (2009) NAS Award for Scientific Discovery (2015) Genetics Society of America Ira Herskowitz Award (2020) Labs & Collaborations : Leads the Weissman Lab at MIT/Whitehead Institute, co-leads the Laboratory for Genomic Research with GlaxoSmithKline, and chairs the Stowers Institute Scientific Advisory Board.

• Protein Folding
• Systems Biology
• Genomics
• +۶ مورد دیگر

Prof Wen Wang is Professor of Biomedical Engineering and Vice-Principal and Executive Dean for Science and Engineering at Queen Mary University of London, affiliated with the School of Engineering and Materials Science and the Centre for Bioengineering. He is a Chartered Engineer and holds fellowships from the Institution of Mechanical Engineers (FIMechE), Higher Education Academy (FHEA), American Institute for Medical and Biological Engineering (FAIMBE), and the Royal Academy of Engineering (FREng), reflecting his leadership and technical excellence in engineering and biomedical sciences. His research focuses on vascular bioengineering , biomaterial mechanics , and cell biomechanics , with particular emphasis on the endothelial glycocalyx , vascular stem cells , and transmembrane transport . He employs advanced techniques such as AFM nano-indentation, confocal microscopy, and microfluidic platforms to study the mechanical properties, shear stress responses, and structural stability of biological systems. His work spans from fundamental biophysics to translational applications in drug delivery and cardiovascular disease. Prof Wang has led multidisciplinary research projects in the UK and through international collaborations with partners in the US, China, and Japan. His recent publications highlight sustained contributions to understanding microcapsule mechanics , extracellular vesicles , biofluid dynamics , and biomolecular sensing . His work integrates experimental and computational modeling, particularly in microcirculation and cellular transport phenomena. He has received notable scientific recognition through multiple prestigious fellowships and has published extensively in high-impact journals including Nature Communications , Journal of Controlled Release , Biosensors and Bioelectronics , and Journal of Fluid Mechanics . His research demonstrates a strong trajectory in both fundamental discovery and applied biomedical innovation. Prof Wang actively supervises research and collaborates with clinical and engineering partners at Queen Mary and King's College London. His leadership in the School of Engineering and Materials Science underscores his role in shaping academic strategy and research excellence in science and engineering at Queen Mary University of London.

• Biomedical Engineering
• Vascular Bioengineering
• Biomaterial Mechanics
• +۱۴ مورد دیگر

Professor Luke Chamberlain is a leading researcher at the Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, where he investigates the role of protein S-acylation in health and disease. His work bridges fundamental biochemistry with therapeutic discovery, focusing on the zDHHC family of enzymes and their impact on cellular signaling, membrane trafficking, and disease mechanisms. Education: PhD in Role of Cysteine-String Protein in Regulated Exocytosis, University of Liverpool (1998) BSc in Microbiology, University of Edinburgh (1994) His research is primarily focused on protein S-acylation (palmitoylation) , a reversible lipid modification that regulates protein localization, stability, and function. He explores how defects in this process contribute to neurodegenerative diseases, cancer, and diabetes. His lab employs advanced techniques such as click chemistry, confocal microscopy, proteomics, and behavioral analyses to dissect molecular mechanisms. The recent publications highlight trends in understanding substrate specificity of zDHHC enzymes , development of inhibitors , and the regulatory role of S-acylation in metabolic and neurological pathways . His work increasingly emphasizes chemical biology approaches to target S-acylation therapeutically. Scientific Awards: No awards explicitly mentioned in the text. Prof. Chamberlain actively mentors postdoctoral researchers and prospective PhD students, offering support for fellowship applications. He is Principal Investigator on multiple grants, including an integrated analysis of S-acylation dynamics (BBSRC-funded) and a Strathclyde-led network with Thailand. His professional activities include serving as an examiner for PhD theses, chairing international conferences such as the FASEB meeting on Protein Lipidation, and participating in research visits to institutions like Tsinghua and Peking University. Labs and Facilities: His research group utilizes the Leica SP8 Confocal Microscope facility at the Strathclyde Institute, enabling high-resolution imaging of protein localization and dynamics in live and fixed cells.

• Protein S-acylation
• Palmitoylation
• Post-translational modifications
• +۱۲ مورد دیگر

John Hanrahan is a Professor in the Department of Physiology at McGill University, leading the Cystic Fibrosis Transmembrane Regulator Function Laboratory. His research focuses on understanding epithelial chloride transport mechanisms, particularly the CFTR protein’s role in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). He employs electrophysiology, imaging, and molecular biology techniques to study CFTR structure-function relationships and develop therapeutic correctors for CFTR mutations. Education: BSc(Hon) from Dalhousie University, PhD from University of British Columbia, and postdoctoral training at Yale University. Research emphasizes: 1) CFTR clustering dynamics and lipid membrane interactions, 2) CFTR corrector drug development (e.g., MCG1516A, LAU-7b), 3) CFTR’s role in mucus production and host defense, and 4) pharmacological modulation of cyclic nucleotide pathways. Recent work explores combinations of CFTR modulators and lipid metabolism interventions to address CF pathophysiology. Key findings include demonstrating lipid-driven CFTR clustering defects in CF and identifying novel compounds that restore CFTR trafficking. His studies also reveal CFTR’s interplay with bitter taste receptors (T2R14) and PDE enzymes in immune responses.

• Cell Biology
• Molecular Biology
• Cystic Fibrosis Research
• +۳ مورد دیگر

Gunnar von Heijne serves as Professor of Theoretical Chemistry at Stockholm University, a position he has held since 1994, and as Director of the Center for Biomembrane Research since 2006. Previously, he directed the Stockholm Bioinformatics Center from 2000-2006. His academic career includes appointments at Karolinska Institute as Associate Professor (1989-1994), University of Munich as Full Professor of Computer Science (1999-2002), and ETH Zurich as Professor of Computer Science (2003). Dr. von Heijne earned his Ph.D. in Theoretical Physics from the Royal Institute of Technology, Stockholm in 1980. His research focuses on protein sorting and membrane protein biogenesis, with groundbreaking contributions including the discovery of the "(-1,-3)-rule" for signal peptide cleavage sites and the "positive inside" rule for membrane protein topology. He has developed essential bioinformatics tools such as SignalP, TargetP, and TMHMM that are widely used in the field. His work spans both computational methods development and experimental validation across E. coli and eukaryotic systems, with recent emphasis on dual-topology membrane proteins and their evolutionary significance. His research has established fundamental principles in membrane protein biology and provided essential tools for the global research community. Dr. von Heijne's publications have received approximately 75,000 citations with an h-index of 102, reflecting his significant impact on molecular biology, bioinformatics, and membrane protein research. The T. Svedberg Award, The Swedish Biochemical Society (1990) The Göran Gustafsson Prize, The Swedish Academy of Sciences (1995) The Arrhenius Medal, The Swedish Chemical Society (1997) Elected member of the Royal Swedish Academy of Sciences (1997) Elected member of the Academia Europaea (1998) "Excellence" Award, the Swedish Research Council (2002) Honorary Doctorate, Åbo Akademi (2008) The van Deenen Medal, Utrecht University (2009) The Accomplishment by a Senior Scientist Award of the International Society for Computational Biology (2012) Dr. von Heijne has supervised 16 Ph.D. students since 1991 and has served extensively on academic committees, including as faculty examiner for doctoral defenses at multiple international institutions. He has chaired the Nobel Committee for Chemistry since 2007 and has participated on editorial boards of leading journals including Journal of Molecular Biology and EMBO Journal. As Director of the Center for Biomembrane Research, he leads an interdisciplinary team investigating membrane protein structure, function, and biogenesis through integrated experimental and computational approaches, advancing our understanding of fundamental cellular processes.

• Molecular Biology
• Cell Biology
• Bioinformatics
• +۵ مورد دیگر